NCT03802357 Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients Status UNKNOWN Phase NA
NCT03636347 A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. Status COMPLETED Phase PHASE2
NCT03455686 Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease Status RECRUITING Phase NA
NCT03385395 Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency Status WITHDRAWN Phase PHASE2
NCT03285100 The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation Status UNKNOWN Phase N/A
NCT03172455 Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) Status NO_LONGER_AVAILABLE Phase N/A
NCT03114020 Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency Status COMPLETED Phase PHASE2
NCT03039335 The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency Status COMPLETED Phase N/A
NCT02691611 Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency Status COMPLETED Phase N/A
NCT02168686 Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency Status COMPLETED Phase PHASE1/PHASE2
NCT01676688 Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home Status COMPLETED Phase N/A
NCT00700934 Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema Status UNKNOWN Phase N/A
NCT00571272 Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) Status SUSPENDED Phase N/A
NCT00460096 Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency Status COMPLETED Phase PHASE2/PHASE3
NCT00430768 Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency Status COMPLETED Phase PHASE1
NCT00396006 Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor) Status COMPLETED Phase PHASE4
NCT00377416 Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency Status COMPLETED Phase EARLY_PHASE1
NCT00301366 The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency Status COMPLETED Phase PHASE3